Copyright
©2005 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2005; 11(2): 280-284
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.280
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.280
Table 1 Inhibitory effect of resveratrol on implanted tumors in nude mice (mean±SD).
| Group | Number of animals | Volume of tumors (mm3) | Inhibition rate% | ||
| Beginning | Ending | Beginning | Ending | ||
| Control group | |||||
| 0.2 mL saline | 5 | 5 | 20.49±0.99 | 498.73±10.74 | |
| DMSO | |||||
| 1500 mg/kg | 5 | 5 | 20.07±1.24 | 506.17±8.70 | |
| Resveratrol | |||||
| 500 mg/kg | 5 | 5 | 20.44±1.76 | 448.04±6.32a | 10.58 |
| 1000 mg/kg | 5 | 5 | 21.27±1.73 | 357.55±6.34a | 29.68 |
| 1500 mg/kg | 5 | 5 | 21.32±1.72 | 312.39±9.93a | 39.14 |
- Citation: Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11(2): 280-284
- URL: https://www.wjgnet.com/1007-9327/full/v11/i2/280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i2.280